KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Common Equity (2016 - 2026)

Zimmer Biomet Holdings has reported Common Equity over the past 18 years, most recently at $12.7 billion for Q1 2026.

  • For Q1 2026, Common Equity rose 2.17% year-over-year to $12.7 billion; the TTM value through Mar 2026 reached $12.7 billion, up 2.17%, while the annual FY2025 figure was $12.7 billion, 1.78% up from the prior year.
  • Common Equity for Q1 2026 was $12.7 billion at Zimmer Biomet Holdings, roughly flat from $12.7 billion in the prior quarter.
  • Over five years, Common Equity peaked at $12.8 billion in Q3 2025 and troughed at $12.0 billion in Q1 2022.
  • A 5-year average of $12.4 billion and a median of $12.5 billion in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: fell 5.05% in 2022 and later rose 3.83% in 2023.
  • Year by year, Common Equity stood at $12.0 billion in 2022, then increased by 3.83% to $12.5 billion in 2023, then decreased by 0.1% to $12.5 billion in 2024, then increased by 1.78% to $12.7 billion in 2025, then dropped by 0.19% to $12.7 billion in 2026.
  • Business Quant data shows Common Equity for ZBH at $12.7 billion in Q1 2026, $12.7 billion in Q4 2025, and $12.8 billion in Q3 2025.